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Restoration of therapeutic transgene expression by administering hematopoietic stem 
cell gene therapy (SCGT) is largely thought to be beneficial for treatmenting primary 
immunodeficiencies (PIDs). However X-linked chronic granulomatous disease 
(XCGD), which is characterized by impaired neutrophil functionality, is unique in 
that the persistence of gene marked cells following SCGT is transient only including 
the most recent clinical trial carried out in Japan last year. During the defense of his 
thesis, Mr. Lin Huan-Ting described the following results: 
 
1. An efficient protocol was developed for differentiating neutrophils first from 
embryonic stem cells (ESCs) and then induced pluripotent stem cells (iPSCs). 
Differentiated neutrophils exhibited the characteristic features of peripheral 
blood neutrophil thus underlining the validity of the protocol to model a disease 
affecting neutrophil functionality. 
 
2. During the characterization of neutrophils, Mr. Lin discovered that the 
combination of CD64 and CD15 allowed him to accurately distinguish between 
developing and mature neutrophils within the same culture. This was used to 
optimize a multi-colored method of analysis by FACS. Therefore specific 
differentiating cell populations (developing or mature) could be targeted 
alongside concomitant analyses of these cells.  
 
3. Patient autologous iPSCs could be successfully generated from an XCGD patient 
that possessed all characteristic features of pluripotent stem cells. The same point 
mutation that had been identified in the patient was retained in these XCGD 
iPSCs. Indeed, mature neutrophils differentiated from untransduced XCGD 
iPSCs showed functional impairment in generating ROS thus indicating that 
iPSCs could successfully recapitulate the disease phenotype. 
 
4. In order to accurately correlate transgene expression with functional recovery, 
Mr. Lin described the use of an emerging technology called droplet digital PCR 
(ddPCR) to accurately and reliably estimate the vector copy number (VCN) in 
transduced cells. Using purified gDNA as template, the concentration of the 
transgene and that of a reference control was quantified per unit volume of input. 
The VCN value was calculated as the ratio between the two concentrations. 
 
5. To mimic the clinical scenario, integrating alpharetroviral vectors were used to 
transduce XCGD iPSCs. After differentiating into neutrophils, it was found that 
despite transduced cells carrying multiple provirus insertions, cellular recovery 
in terms of gp91phox, the deficient protein, and ROS production in mature 
neutrophils was considerably less compared with the healthy wild type control. 
Silencing alone would not fully explain these observations because puromycin 
selection was maintained throughout such that only transgene positive cells were 
analyzed. 
 
6. By analyzing the expression of the intracellular components of NAPDH oxidase 
(p47 and p67phox) there was a negative correlation with transgene-derived 
gp91phox in mature neutrophils. 
 
7. Central to his study, Mr. Lin demonstrated the expression of “ectopic” gp91phox 
only in the developing fraction of neutrophils differentiated from transduced 
XCGD iPSCs. No expression was detected in the corresponding fraction from 
healthy controls.  
 
8. It was found that developing neutrophils ectopically expressing gp91phox 
showed raised levels of certain ER stress markers. Although this may not be the 
main mechanism, it has been reported that sustained ER stress can lead to cell 
apoptosis, which may be the ultimate fate of these cells. 
 
9. To determine the hierarchical transition in maturation of in vitro cultured 
neutrophils, FACS sorting was performed to obtain only developing neutrophils 
differentiated from both XCGD and healthy control iPSCs. Following a further 
two days of differentiation, mature neutrophils appeared in the culture suggesting 
that they originated from this developing fraction. 
 
10. During the time-course assessment of gp91phox expression, mature neutrophils 
differentiated from healthy iPSCs showed peak expression after 7 days. In 
gp91phox-transduced cells, expression levels were comparable with healthy 
controls up to 5 days after differentiation. However, it was abruptly lost and by 
day 7, gp91phox expression became almost undetectable.    
 
11. In this study, whether the control (no gp91phox) or therapeutic (gp91phox-
conatining) vector was used, transduced cells can be identified by NGFR 
expression. Time-course assessment revealed that expression was sustained 
through 7 days of differentiation in control vector-transduced cells but in the 
therapeutic group, NGFR expression was abruptly lost after 5 days. Since both 
vector constructs are very similar, neither would be considered to be more 
susceptible to silencing than the other. Therefore silencing alone is unlikely to 
fully explain the disappearance of transgene-derived gp91phox. 
 
12. By analyzing cell viability over time, on day 3, there was no significant levels of 
cell death detected in the developing fraction in any of the experimental groups. 
However on day 5, cells ectopically expressing gp91phox showed an increased 
susceptibility for undergoing cell death. By day 7, the same group of therapeutic 
vector-transduced cells showed normal cells viability, which is consistent with 
the previous observation that ectopic gp91phox expression was lost by this time 
point. 
 
In summary, Mr. Lin found that ectopic gp91phox expression may compromise the 
viability of developing neutrophils, which may at least partially explain why their 
transient persistence in the peripheral blood. He was successful in demonstrating the 
practical utility of iPSC-based disease modeling systems. By intensively repeating 
experiment, he used it to optimize multi-color FACS analysis permitting concomitant 
surface staining and florescence detection-based cell assays. In collaborating with 
BioRad, the ddPCR system may eventually be used to estimate VCN states in a 
variety of research and clinical settings. Indeed, a second manuscript based on the 
ddPCR work has been submitted for publication and is currently under review. Most 
importantly the core findings from his work may well have a significant clinical 
impact. In this study, the potentially detrimental effects of non-physiologically 
regulated transgene expression is clearly shown despite conventional thinking that it 
is largely beneficial. More specific to XCGD, there is valuable insight into the 
underlying pathophysiological mechanisms and for the first time, there is some 
experimental evidence to support a reason that could explain why there has been 
limited success from clinical trials. Taken together, given the number of noticeable 
discoveries and achievements made over the course of this study, it is my 
recommendation that Mr. Lin should be conferred with his Ph.D. degree by the 
University of Tokyo. 
